School of Medicine


Showing 21-30 of 48 Results

  • George F Tidmarsh

    George F Tidmarsh

    Adjunct Professor, Pediatrics - Neonatology

    Bio Dr. Tidmarsh received M.D. and Ph.D. from Stanford University, where he also completed fellowship training in Pediatric Oncology and Neonatology and is currently Adjunct Faculty of Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years after fellowship prior to devoting his full time to clinical research and development in order to bring new treatments through the FDA approval process. Dr. Tidmarsh was President, Chief Executive Officer, Secretary and a Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. While at La Jolla, Dr. Tidmarsh helped discover the use of angiotensin II for the treatment of shock and led all aspects of the development including approval by the US FDA and the EMA for the treatment of patients suffering from distributive shock. He also led the development of artesunate for the treatment of severe malaria, now pending action for potential approval at the FDA. Dr. Tidmarsh has over 30 years of experience in biotechnology, including the successful clinical development of three FDA-approved drugs. He previously served as the Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. He also founded Threshold Pharmaceuticals, Inc. and held senior positions at Coulter Pharmaceutical, Inc. (acquired by GlaxoSmithKline) and SEQUUS Pharmaceuticals, Inc. (acquired by Johnson & Johnson). While at Coulter and SEQUUS, Dr. Tidmarsh led the clinical development of BEXXAR and Doxil, respectively, two FDA-approved anti-cancer agents.

    At Stanford, Dr. Tidmarsh is devoted to teaching clinical research and development to residents, fellows and junior faculty. In addition, he is working to help improve the quality of medical care through various efforts which include serving on the board of Lucile Packard Foundation for Children's Health.

  • Seda Tierney

    Seda Tierney

    Associate Professor of Pediatrics (Cardiology) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests Assessment of vascular health s in children by non-invasive modalities

    Echocardiography and outcomes in congenital heart disease

  • Sara L. (Sally) Tobin

    Sara L. (Sally) Tobin

    Sr Research Scholar, Pediatrics - Center for Biomedical Ethics

    Current Research and Scholarly Interests Tobin is a Senior Research Scholar at the Stanford Center for Biomedical Ethics. She obtained her Ph.D. in Developmental Biology from the University of Washington and did postdoctoral research in Genetics at the University of California, Berkeley and in Biochemistry at the University of California, San Francisco. She became a faculty member at the University of Oklahoma College of Medicine in 1983 and moved to Stanford University in 1996. Her research contributions have been published in prestigious journals such as Cell, Nature, Genes & Development, Neuron, and Journal of Cell Biology.

    Projects

    With her collaborator, graphic designer Ann Boughton, Tobin has completed the production of three educational multimedia CD-ROM discs about the genetic revolution in medical care sparked by the rapid advances in our knowledge about the human genome. An on-line version derived and updated from these CDs is pending release through Twisted Ladder Media, and is entitled: "The New Genetics: Medicine and the Human Genome. Molecular Concepts, Applications, and Ramifications." In addition, Tobin and Boughton have collaborated on educational websites on inherited risk of breast cancer and on hereditary colorectal cancer with the Stanford Cancer Genetics Clinic.

    Tobin's current major research interests include an educational project funded by the National Science Foundation to create and evaluate innovative modules for undergraduates entitled, "The New Genetics: Electronic Tools for Educational Innovation." The modules are presented in on-line form as an electronic course and are accompanied by workbook exercises and problem sets. The content includes principles of genetics, molecular genetic technologies, applications in medicine, environmental biology, agriculture, and society, as well as implications. In addition, she is collaborating on two projects that are exploring the ramifications of using genetic information about addiction risk in the judicial system.

    Tobin is a member of the Benchside Consultation Team for the Center for the Integration of Research on Genetics and Ethics, and she evaluates clinical protocols for ethical issues for the Clinical Translational Research Program.

  • Sarina Tom

    Sarina Tom

    Education Operations Manager, Pediatrics

    Current Role at Stanford Education Operations Manager
    Office of Pediatric Education
    Stanford Department of Pediatrics

  • Michael Tracy

    Michael Tracy

    Clinical Assistant Professor, Pediatrics - Pulmonary Medicine

    Bio Dr. Tracy is a Clinical Assistant Professor in the Division of Pediatric Pulmonary. His clinical interests include care for children with bronchopulmonary dysplasia (BPD), chronic respiratory failure, mechanical ventilation, childhood interstitial lung disease, and cystic fibrosis. He serves as the director of the BPD Clinic, and co-director of the Cardiac and Respiratory care for Infants with BPD (CRIB) Program. He is the physician lead for the inpatient Pulmonary consult service at LPCH. Dr. Tracy is currently involved clinical and translational research projects in the area of BPD and cystic fibrosis. With regard to medical education, he was formerly a chief resident in pediatrics at LPCH, and currently serves as a faculty coach in the pediatric residency program.

Footer Links:

Stanford Medicine Resources: